4.7
BDG LifeSciences is a distinguished bioinformatics company established in 2010 and operates globally. Headquartered in India the company specializes in facilitating workshops, training programs, novel & innovative research projects, and online courses in technologies of bioinformatics & life science. The company is registered under the Ministry of MSME (Micro, Small, and Medium Enterprises), Government of India, with the registration number UDYAM-UP-01-0019151. Recently, BDG Lifesciences, India has authorized BBR Group Pty Ltd., Australia (ACN 608 550 849), to operate its programs in Australia & New Zealand.
With a focus on practical application of technology, where participants work on their own computer/laptop on software/servers, BDG LifeSciences has been a leader in the sector for the last 14 years.
To view the pictures of our previous events click here-1 and click here-2. To view, the listing of upcoming events kindly click here and our previous workshops can be viewed here. To view the video feedback of our previous events kindly visit our YouTube Channel
On a huge demand we have launched our next 3-day complete hands-on Online Workshop in Droplet Digital PCR Data Analysis. This program will be an extensive hands-on training program in which everyday 120-150 minutes of live session will be conducted by Dr Shahul Hameed and participants will run the processes on their own computer systems with complete learning of this revolutionary technology. Video recording of each session will be provided at the end of the session to give the user a unique learning experience. On successful completion of the course participation certificate will be awarded.
INTRODUCTION
Droplet Digital PCR (ddPCR) is a novel method for nucleic acid quantification that allows for absolute quantification of DNA or RNA targets in a sample. Unlike traditional quantitative PCR (qPCR), which uses fluorescence signals to measure amplification of target nucleic acids, ddPCR partitions a sample into thousands of individual droplets, each serving as an individual reaction vessel. The amplification of the target nucleic acid is then carried out within each droplet, allowing for precise quantification of the target molecule. After amplification, the droplets are read to determine whether they contain amplified target molecules or not. This technology has become increasingly popular in recent years due to its high precision, sensitivity, and reproducibility, as well as its ability to detect rare targets with greater accuracy.
Droplet digital PCR has numerous applications in research and clinical settings. It is commonly used in cancer research to detect mutations, copy number variations, and gene fusions. It is also used in infectious disease research to quantify viral load and detect drug resistance mutations. Other applications include the detection of rare genetic disorders, gene expression analysis, and monitoring of gene editing and gene therapy. Additionally, ddPCR has the potential to be used in non-invasive prenatal testing and liquid biopsy for cancer detection. Overall, the high accuracy and sensitivity of ddPCR make it a powerful tool for a wide range of applications in biomedical research and diagnostics.
TOPICS
OUTCOME OF THIS PROGRAM: This droplet digital PCR data analysis workshop can provide participants with a range of learning outcomes, including:
Overall, the workshop can provide participants with the necessary skills and knowledge to analyze ddPCR data effectively and make significant contributions to biomedical research and diagnostics.
TIME- New York 19:30 (PREVIOUS DAY) / London 00:30 / Paris 01:30 / Dubai 04:30 / New Delhi 6:00 / Singapore 08:30 / Sydney 11:30
TARGET AUDIENCE
Student: Bachelor, Masters, PhD, MBBS, MD students as well as Faculty and Professors from Microbiology, Biochemistry, Biotechnology, Immunology, Medicine, Pharmacy, Pharmaceutical Chemistry, Biomedical Technology, Genetics, Bioinformatics, Plant Science and Life Sciences.
Professionals: Resident Doctors, Biotechnology, Bioinformatics, Medicine and Pharmaceutical scientists from industry, academia, and regulatory agencies. Hands-on exercises will be performed individually using software tools on your own laptops. (no prior experience required).
RESOURCE PERSON
Dr. Shahul Hameed is a researcher and his research involves developing CRISPR based gene therapy for Muscular dystrophy and Sickle Cell Anaemia. He is also involved in the development of novel delivery systems for gene therapy. His research interest extends to design of mRNA based therapeutics and design of Artificial Intelligence based Digital health & Imaging tools. In Collaboration with Dystrophy Annihilation Research Trust, his lab was involved in gene editing of DMD gene for development of CRISPR based therapeutics. [Nov 2018 to Aug 2022]
He has worked as Senior Assistant Professor at B.S. Abdur Rahman Crescent University, Chennai and earlier at Bannari Amman Institute of Technology, Erode. He was involved in teaching biotechnology subjects like Protein Engineering, Genomics and Proteomics, Structural Biology, Pharmaceutical Biotechnology, Genetic Engineering and Chemical Reaction Engineering to students. His research work involved Drug Design against S100A4 oncoprotein. Further development of Machine Learning based tools for predicting thermodynamic stability of enzyme mutants. He was selected through ERASMUS to conduct workshops on drug design and protein engineering at University of Nottingham, UK.
He is a PhD in Biological Sciences from Indian Institute of Science(IISc), Bangalore. At IISc, his research work involved Protein Engineering and Structural Characterization of the engineered mutants using Nuclear magnetic resonance spectroscopy and other biophysical methods. His research work also involved characterization of Protein-Protein interactions using experimental techniques, like NMR and Mass spectrometry, genetic engineering and Computer simulations.
He did his postdoctoral training at Tata Institute of Fundamental Research, Mumbai. There his work involved development of novel NMR techniques to study huge protein complexes. His work also involved Cloning, Protein Expression and Purification of motor proteins.
T & C